Corona Remedies acquires Wokadine brand from Dr. Reddy’s in India

Corona Remedies has acquired Wokadine marque from Dr. Reddy’s Laboratories successful India.

The acquisition, effectual March 30, marks the company’s introduction into the ₹648 crore Povidone Iodine marketplace successful India. Wokadine is ranked fig 2 successful the marketplace and the marque holds beardown imaginable for accelerated maturation nether its stewardship, Corona said connected Monday.

Wokadine comprises 14 SKUs having antithetic applications. The institution said the acquisition volition beryllium afloat funded done interior accruals and cash.

For Corona Remedies, which continuously assesses some integrated and inorganic maturation opportunities, the latest acquisition volition heighten and fortify existing merchandise portfolio, V-P Corporate Strategy and Business Development Tejas Kothari said successful a release.